Xxera/openscience/retractions

Record #19410

A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors

Journal

Cancer Discovery

Publisher

American Association for Cancer Research

Original paper date

Nov 21, 2016

Original DOI

10.1158/2159-8290.CD-16-0512

Country

🇪🇸 Spain · 🇺🇸 United States

Institution

Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain · Hematology and Medical Oncology Department, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain · Radiology Department, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain · Genentech, Inc., South San Francisco, California

Open access

No

Article type

Broad categories

(BLS) Biochemistry (BLS) Biology - Cellular (BLS) Toxicology (HSC) Medicine - Oncology

Citation lifecycle

How this paper is being cited

Pre-retraction

24

Same day

1

Post-retraction

120

% post-retraction

82.8%

~12.3 citations/yr before retraction · ~15.2 citations/yr after

— citing papers

Who is still citing this work

Loading…